Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.184.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.06M | 4.40M | 4.26M | 3.84M | 1.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.06M | 4.40M | 4.26M | 3.84M | 1.88M |
| Cost of Revenue | 1.74M | 1.96M | 1.89M | 1.75M | 1.05M |
| Gross Profit | 2.32M | 2.44M | 2.37M | 2.09M | 828.00K |
| SG&A Expenses | 16.98M | 16.12M | 15.80M | 14.95M | 14.15M |
| Depreciation & Amortization | 7.00K | 29.00K | 51.00K | 73.00K | 88.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.72M | 30.37M | 28.93M | 27.14M | 25.13M |
| Operating Income | -40.53M | -25.97M | -24.67M | -23.30M | -23.25M |
| Income Before Tax | -50.22M | -60.78M | -63.42M | -58.21M | -60.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -50.22 | -60.78 | -63.42 | -58.21 | -60.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -50.22M | -60.78M | -63.42M | -58.21M | -60.66M |
| EBIT | -40.53M | -25.97M | -24.67M | -23.30M | -23.25M |
| EBITDA | -37.77M | -23.77M | -22.72M | -21.58M | -21.68M |
| EPS Basic | -1.62 | -2.83 | -3.48 | -3.53 | -4.40 |
| Normalized Basic EPS | -0.79 | -0.61 | -0.75 | -0.89 | -1.18 |
| EPS Diluted | -2.34 | -2.83 | -3.48 | -3.53 | -4.40 |
| Normalized Diluted EPS | -0.79 | -0.61 | -0.75 | -0.89 | -1.18 |
| Average Basic Shares Outstanding | 121.83M | 107.13M | 88.81M | 69.66M | 52.23M |
| Average Diluted Shares Outstanding | 121.83M | 107.13M | 88.81M | 69.66M | 52.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |